Plasma-Free Fatty Acids, Fatty Acid–Binding Protein 4, and Mortality in Older Adults (from the Cardiovascular Health Study)

Dec 1, 2016 by in CARDIOLOGY Comments Off on Plasma-Free Fatty Acids, Fatty Acid–Binding Protein 4, and Mortality in Older Adults (from the Cardiovascular Health Study)

Plasma-free fatty acids (FFAs) are largely derived from adipose tissue. Elevated levels of FFA and fatty acid–binding protein 4 (FABP4), a key cytoplasmic chaperone of fatty acids, have been associated…

read more

Comparison of Risk of Acute Kidney Injury After Primary Percutaneous Coronary Interventions With the Transradial Approach Versus the Transfemoral Approach (from the PRIPITENA Urban Registry)

Dec 1, 2016 by in CARDIOLOGY Comments Off on Comparison of Risk of Acute Kidney Injury After Primary Percutaneous Coronary Interventions With the Transradial Approach Versus the Transfemoral Approach (from the PRIPITENA Urban Registry)

The risk of acute kidney injury (AKI) is a major issue after percutaneous coronary interventions (PCIs), especially in the setting of ST-elevation myocardial infarction. Preliminary data from large retrospective registries…

read more

Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction (from the Strategic Reperfusion Early After Myocardial Infarction [STREAM] Study)

Dec 1, 2016 by in CARDIOLOGY Comments Off on Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction (from the Strategic Reperfusion Early After Myocardial Infarction [STREAM] Study)

Although a fibrinolytic pharmacoinvasive strategy is recommended for patients with ST elevation myocardial infarction (STEMI) unable to undergo timely primary percutaneous coronary intervention (PCI), there are limited data addressing outcomes…

read more

Ability of Low Antihypertensive Medication Adherence to Predict Statin Discontinuation and Low Statin Adherence in Patients Initiating Treatment After a Coronary Event

Dec 1, 2016 by in CARDIOLOGY Comments Off on Ability of Low Antihypertensive Medication Adherence to Predict Statin Discontinuation and Low Statin Adherence in Patients Initiating Treatment After a Coronary Event

Low statin adherence and discontinuation of statins are common in patients with coronary heart disease. We hypothesized that low antihypertensive medication adherence would be associated with future statin discontinuation and…

read more
Get Clinical Tree app for offline access